Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Terns Pharmaceuticals Inc’s stock clocked out at $8.03, up 2.82% from its previous closing price of $7.81. In other words, the price has increased by $2.82 from its previous closing price. On the day, 0.66 million shares were traded. TERN stock price reached its highest trading level at $8.05 during the session, while it also had its lowest trading level at $7.73.
Ratios:
To gain a deeper understanding of TERN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 24.70 and its Current Ratio is at 24.70. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Barclays on September 17, 2025, initiated with a Overweight rating and assigned the stock a target price of $15.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 01 ’25 when Kuriakose Emil sold 944 shares for $7.85 per share. The transaction valued at 7,407 led to the insider holds 51,520 shares of the business.
Kuriakose Emil sold 853 shares of TERN for $3,640 on Jul 01 ’25. The Chief Medical Officer now owns 52,464 shares after completing the transaction at $4.27 per share. On Jun 27 ’25, another insider, Gengos Andrew, who serves as the Chief Financial Officer of the company, bought 10,000 shares for $3.93 each. As a result, the insider paid 39,283 and bolstered with 25,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TERN now has a Market Capitalization of 702713664 and an Enterprise Value of 388401728.
Stock Price History:
The Beta on a monthly basis for TERN is -0.04, which has changed by -0.029020548 over the last 52 weeks, in comparison to a change of 0.16766965 over the same period for the S&P500. Over the past 52 weeks, TERN has reached a high of $8.46, while it has fallen to a 52-week low of $1.87. The 50-Day Moving Average of the stock is 16.56%, while the 200-Day Moving Average is calculated to be 71.63%.
Shares Statistics:
It appears that TERN traded 1.08M shares on average per day over the past three months and 1014310 shares per day over the past ten days. A total of 87.47M shares are outstanding, with a floating share count of 69.58M. Insiders hold about 20.49% of the company’s shares, while institutions hold 83.04% stake in the company. Shares short for TERN as of 1757894400 were 8308078 with a Short Ratio of 7.67, compared to 1755216000 on 7119785. Therefore, it implies a Short% of Shares Outstanding of 8308078 and a Short% of Float of 9.5.
Earnings Estimates
Current recommendations for the stock of the company come from 9.0 analysts. The consensus estimate for the next quarter is -$0.3, with high estimates of -$0.24 and low estimates of -$0.38.
Analysts are recommending an EPS of between -$1.06 and -$1.34 for the fiscal current year, implying an average EPS of -$1.15. EPS for the following year is -$1.22, with 9.0 analysts recommending between -$0.75 and -$1.49.
